Announcements Trials
Browse Landscape

Phase

Phase 2 5Phase 3 3Phase 4 1

Status

Completed 2Recruiting 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Myeloid 3Classical hematology 1

Conditions

Colorectal Neoplasms 7Colonic Neoplasms 6Recurrence 4Prostatic Neoplasms 4Neoplasms 4Polycythemia Vera 3Venous Thromboembolism 2Thrombocythemia, Essential 2Rectal Neoplasms 2Myocardial Infarction 2Esophageal Neoplasms 2Cardiovascular Diseases 2Adenoma 2Vascular Diseases 1Thrombosis 1Thrombocytopenia 1Stomach Neoplasms 1Primary Myelofibrosis 1Precancerous Conditions 1Pathologic Processes 1Node Positive HER2 Negative Breast Cancer 1Neoplasms by Site 1Neoplasm Metastasis 1Myocardial Ischemia 1Myeloproliferative Disorders 1Multiple Myeloma 1Lynch syndrome I (site-specific colonic cancer) 1Lymphoma, Follicular 1Liver Cirrhosis 1Ischemic Stroke 1

Interventions

Hydroxyurea 8ruxolitinib 5Aspirin 3peginterferon alfa-2b 2peginterferon alfa-2a 2liposomal amphotericin B 2Phlebotomy 2Early Intervention, Educational 211-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene 2pomalidomide 1givinostat hydrochloride 1givinostat 1bomedemstat 1anagrelide 1Pipobroman 1Pharmacogenomic Testing 1Ondansetron 1N(4)-oleylcytosine arabinoside 1Morphine 1Lenalidomide 1Ketamine 1Interferons 1Interferon-alpha 1Hypericum extract LI 160 1Fentanyl 1Dextromethorphan 1Caspofungin 1Asian ginseng 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Polycythemia Vera × Aspirin × Clear all
NCT05198960 2026-03-20

AVAJAK

University Hospital, Brest

Phase 3 Recruiting
1,308 enrolled
Classical hematologyMyeloid

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT06002490 2024-11-08

A Study to Evaluate P1101 in Japanese PV Patients

PharmaEssentia Japan K.K.

Phase 3 Completed
21 enrolled
Myeloid

Myeloproliferative Disorders, Polycythemia Vera

NCT01259856 2019-04-30

Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET)

Icahn School of Medicine at Mount Sinai

Phase 3 Completed
168 enrolled 16 charts
Myeloid

Polycythemia Vera, Thrombocythemia, Essential

Data powered by HemOnc (CC BY 4.0) Colophon âš¡